Name: UMIN ID:
Unique ID issued by UMIN | UMIN000021641 |
---|---|
Receipt number | R000024899 |
Scientific Title | Perioperative CapeOx therapy for clinical stage III gastric cancer; a phase II study (OGSG1601) |
Date of disclosure of the study information | 2016/04/01 |
Last modified on | 2022/11/06 00:30:37 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2016/03/27 19:30:13 | ||
2 | Update | 2016/04/05 22:29:46 | Key secondary outcomes Key secondary outcomes |
|
3 | Update | 2016/04/05 22:31:16 | Interventions/Control_1 Interventions/Control_1 |
|
4 | Update | 2016/04/05 22:45:03 | Name of primary person or sponsor Organization |
|
5 | Update | 2016/10/20 01:15:04 | Recruitment status |
|
6 | Update | 2016/11/15 23:55:38 | Name of person sending information Name of person sending information Organization Organization Division name Division name Address Address TEL |
|
7 | Update | 2017/05/10 23:08:25 | Recruitment status |
|
8 | Update | 2018/02/22 00:05:52 | Email |
|
9 | Update | 2018/04/09 07:23:52 | Last follow-up date |
|
10 | Update | 2018/08/01 06:52:43 | UMIN ID1 |
|
11 | Update | 2020/01/05 21:24:53 | Date of IRB |
|
12 | Update | 2020/01/05 21:28:18 | Number of participants that the trial has enrolled |
|
13 | Update | 2020/01/22 22:42:14 | Anticipated trial start date |
|
14 | Update | 2021/04/04 16:47:11 | Recruitment status Date analysis concluded |
|
15 | Update | 2022/11/06 00:30:37 | URL releasing protocol Publication of results URL related to results and publications Results Results Results date posted Date of the first journal publication of results Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |